Vetr Upgrades Valeant After Price Dips By: Benzinga via Benzinga December 07, 2017 at 16:54 PM EST The Vetr crowd on Thursday upgraded its rating on Valeant Pharmaceuticals International, Inc. (NYSE: VRX), from 4 stars (Buy), issued ... Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.